drugset / Trial / NCT01078909

Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation

NCT01078909

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the lowest effective dose of EPA + DHA (300, 600, 900 and 1,800 mg/day delivered as fish oil supplements) that significantly attenuates the inflammatory response to in vivo and ex vivo endotoxin challenge as measured by the production over time of several inflammatory markers.

Timeline

Start
2011-10
Primary completion
2012-11
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Eicosapentaenoic acid Small molecule 300 mg
Subject Eicosapentaenoic acid Small molecule 600 mg
Subject Eicosapentaenoic acid Small molecule 900 mg
Subject Eicosapentaenoic acid Small molecule 1800 mg